The challenge of traditional Chinese medicines for allopathic practitioners.
L D
LD
Karalliedde
C T
CT
Kappagoda
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000975:Antioxidants / Q000627:therapeutic use; D001018:Aortic Diseases / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D001019:Aortic Rupture / Q000209:etiology / Q000378:metabolism / Q000473:pathology / Q000517:prevention & control*; D050197:Atherosclerosis / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D015415:Biomarkers / Q000378:metabolism; D002317:Cardiovascular Agents / Q000737:chemistry / Q000627:therapeutic use*; D000529:Complementary Therapies; D018450:Disease Progression; D004365:Drugs, Chinese Herbal / Q000737:chemistry / Q000627:therapeutic use*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D018836:Inflammation Mediators / Q000378:metabolism; D008055:Lipids / Q000097:blood; D019821:Simvastatin / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D000975:Antioxidants; D015415:Biomarkers; D002317:Cardiovascular Agents; D004365:Drugs, Chinese Herbal; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D018836:Inflammation Mediators; D008055:Lipids; C513941:tongxinluo; D019821:Simvastatin